Anti-epileptic drug brivaracetam is now available for children in Scotland
Children aged four years and older in Scotland will have access to an anti-epileptic drug (AED) brivaracetam as a new treatment option. Pharmaceutical company UCB announced on 10 December that the Scottish Medicines Consortium has accepted expanding the use of the drug.
Genetic research leads to better understanding of common epilepsies
Researchers across the globe have thrown new light on the important role that genetics play in some of the most common epilepsies.
Our CEO Clare Pelham has won a CEO Today United Kingdom Award 2018
We are thrilled to announce that our Chief Executive Officer, Clare Pelham, has won a CEO Today United Kingdom Award 2018 for her work in the charity sector.
Next stage in genetic research brings us closer to understanding epilepsy
More than 800 DNA samples from Epilepsy Society have now been sequenced as part of Genomics England's landmark 100,000 Genomes Project. This means our researchers, bioinformaticians and clinicians are at the exciting stage of being able to analyse the new data, bringing hope of groundbreaking results in the diagnosis, treatment and understanding of epilepsy.
Specialist doctors can now prescribe medicinal cannabis for epilepsy
As of this morning (1 November), specialist doctors in the UK can now prescribe cannabis-based medicines to patients with a limited number of conditions. This includes children with severe epilepsy syndromes.